Grant RadarWorldwide funding

Browse grants Log in Get started

Health Opening SoonPAR-26-091

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-26-091

Eligible Applicants

Organization Types

UniversitiesNGOsSMEsGovernment Agencies

Eligible Countries / Regions

United States

Keywords

National Institutes of HealthPAR-26-091Grants.gov

Related Grants

International Research Scientist Development Award (IRSDA)

Amount not stated

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Amount not stated

05 Jul 2029(972d)

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Amount not stated

10 Nov 2026(4d)

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Amount not stated

15 Oct 2027(343d)

Funding Amount

Amount not stated

USD

The funder has not published an amount yet — check the call documents.

Programme Details

Programme Code

PAR-26-091